245 related articles for article (PubMed ID: 31642343)
1. Rational Engineering and Preclinical Evaluation of Neddylation and SUMOylation Site Modified Adeno-Associated Virus Vectors in Murine Models of Hemophilia B and Leber Congenital Amaurosis.
Maurya S; Mary B; Jayandharan GR
Hum Gene Ther; 2019 Dec; 30(12):1461-1476. PubMed ID: 31642343
[TBL] [Abstract][Full Text] [Related]
2. Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration.
Mary B; Maurya S; Kumar M; Bammidi S; Kumar V; Jayandharan GR
Mol Pharm; 2019 Nov; 16(11):4738-4750. PubMed ID: 31596095
[TBL] [Abstract][Full Text] [Related]
3. AAV mediated genome engineering with a bypass coagulation factor alleviates the bleeding phenotype in a murine model of hemophilia B.
Sarangi P; Kumar N; Sambasivan R; Ramalingam S; Amit S; Chandra D; Jayandharan GR
Thromb Res; 2024 Jun; 238():151-160. PubMed ID: 38718473
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy using self-complementary Y733F capsid mutant AAV2/8 restores vision in a model of early onset Leber congenital amaurosis.
Ku CA; Chiodo VA; Boye SL; Goldberg AF; Li T; Hauswirth WW; Ramamurthy V
Hum Mol Genet; 2011 Dec; 20(23):4569-81. PubMed ID: 21880665
[TBL] [Abstract][Full Text] [Related]
6. Exosome-associated SUMOylation mutant AAV demonstrates improved ocular gene transfer efficiency in vivo.
Maurya S; Jayandharan GR
Virus Res; 2020 Jul; 283():197966. PubMed ID: 32302639
[TBL] [Abstract][Full Text] [Related]
7. Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65.
Georgiadis A; Duran Y; Ribeiro J; Abelleira-Hervas L; Robbie SJ; Sünkel-Laing B; Fourali S; Gonzalez-Cordero A; Cristante E; Michaelides M; Bainbridge JW; Smith AJ; Ali RR
Gene Ther; 2016 Dec; 23(12):857-862. PubMed ID: 27653967
[TBL] [Abstract][Full Text] [Related]
8. High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.
Markusic DM; Herzog RW; Aslanidi GV; Hoffman BE; Li B; Li M; Jayandharan GR; Ling C; Zolotukhin I; Ma W; Zolotukhin S; Srivastava A; Zhong L
Mol Ther; 2010 Dec; 18(12):2048-56. PubMed ID: 20736929
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application.
Monahan PE; Lothrop CD; Sun J; Hirsch ML; Kafri T; Kantor B; Sarkar R; Tillson DM; Elia JR; Samulski RJ
Mol Ther; 2010 Nov; 18(11):1907-16. PubMed ID: 20700109
[TBL] [Abstract][Full Text] [Related]
10. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
[TBL] [Abstract][Full Text] [Related]
11. Combined rod and cone transduction by adeno-associated virus 2/8.
Manfredi A; Marrocco E; Puppo A; Cesi G; Sommella A; Della Corte M; Rossi S; Giunti M; Craft CM; Bacci ML; Simonelli F; Surace EM; Auricchio A
Hum Gene Ther; 2013 Dec; 24(12):982-92. PubMed ID: 24067103
[TBL] [Abstract][Full Text] [Related]
12. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.
Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ
Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787
[TBL] [Abstract][Full Text] [Related]
13. Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis.
Le Meur G; Lebranchu P; Billaud F; Adjali O; Schmitt S; Bézieau S; Péréon Y; Valabregue R; Ivan C; Darmon C; Moullier P; Rolling F; Weber M
Mol Ther; 2018 Jan; 26(1):256-268. PubMed ID: 29033008
[TBL] [Abstract][Full Text] [Related]
14. Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy.
Pennesi ME; Weleber RG; Yang P; Whitebirch C; Thean B; Flotte TR; Humphries M; Chegarnov E; Beasley KN; Stout JT; Chulay JD
Hum Gene Ther; 2018 Dec; 29(12):1428-1437. PubMed ID: 29869534
[TBL] [Abstract][Full Text] [Related]
15. Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.
Weleber RG; Pennesi ME; Wilson DJ; Kaushal S; Erker LR; Jensen L; McBride MT; Flotte TR; Humphries M; Calcedo R; Hauswirth WW; Chulay JD; Stout JT
Ophthalmology; 2016 Jul; 123(7):1606-20. PubMed ID: 27102010
[TBL] [Abstract][Full Text] [Related]
16. Muscle-directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors.
Wang L; Louboutin JP; Bell P; Greig JA; Li Y; Wu D; Wilson JM
J Thromb Haemost; 2011 Oct; 9(10):2009-19. PubMed ID: 21883883
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy rescues cone structure and function in the 3-month-old rd12 mouse: a model for midcourse RPE65 leber congenital amaurosis.
Li X; Li W; Dai X; Kong F; Zheng Q; Zhou X; Lü F; Chang B; Rohrer B; Hauswirth WW; Qu J; Pang JJ
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):7-15. PubMed ID: 21169527
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B.
George LA; Ragni MV; Rasko JEJ; Raffini LJ; Samelson-Jones BJ; Ozelo M; Hazbon M; Runowski AR; Wellman JA; Wachtel K; Chen Y; Anguela XM; Kuranda K; Mingozzi F; High KA
Mol Ther; 2020 Sep; 28(9):2073-2082. PubMed ID: 32559433
[TBL] [Abstract][Full Text] [Related]
19. Gene Therapy Using a miniCEP290 Fragment Delays Photoreceptor Degeneration in a Mouse Model of Leber Congenital Amaurosis.
Zhang W; Li L; Su Q; Gao G; Khanna H
Hum Gene Ther; 2018 Jan; 29(1):42-50. PubMed ID: 28679290
[TBL] [Abstract][Full Text] [Related]
20. Functions of AAV-CMV-F.IX And AAV-EF1alpha-F.IX in gene therapy for hemophilia B.
Wiwanitkit V
Hum Gene Ther; 2007 Feb; 18(2):89-92. PubMed ID: 17266422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
